Mild controlled hypothermia in preterm neonates with advanced necrotizing enterocolitis. 2010

Nigel J Hall, and Simon Eaton, and Mark J Peters, and Melanie P Hiorns, and Nicholas Alexander, and Denis V Azzopardi, and Agostino Pierro
MRCPCH, Institute of Child Health, Department of Paediatric Surgery, 30 Guilford St, London WC1N 1EH, UK. n.hall@ich.ucl.ac.uk

OBJECTIVE Necrotizing enterocolitis (NEC) with multiple organ dysfunction syndrome (MODS) carries significant morbidity and mortality. There is extensive experimental evidence to support investigation of therapeutic hypothermia in infants with these conditions. We aimed to establish the feasibility and safety of mild hypothermia in preterm neonates with NEC and MODS as a prelude to a randomized trial. METHODS This was a prospective, nonrandomized pilot study of 15 preterm infants who were referred for surgical intervention of advanced NEC and failure of at least 3 organs. Whole-body cooling was achieved by ambient temperature adjustment with or without cooling mattress. Three groups (n = 5 per group) were cooled to core temperatures of 35.5 degrees C (+/-0.5 degrees C), 34.5 degrees C, and 33.5 degrees C, respectively, for 48 hours before rewarming to 37 degrees C. Infants were carefully assessed to identify adverse effects that potentially were related to cooling and rewarming. A noncooled group (n = 10) with advanced surgical NEC and MODS was used for comparison. Data are medians (interquartile range). RESULTS Gestational age at birth was 27 weeks (26-30), admission weight was 1.1 kg (1.0-1.7), and admission age was 31 days (12-45). Core temperature was maintained within target range for 90% (88%-97%) of the intended time. Statistically significant relationships were identified between core temperature and heart rate (P < .0001), pH (P < .0001), base excess (P = .003), and blood clot dynamics (longer time to initial clot formation, slower rate of clot formation, and decrease in clot strength; all P < .001) as assessed by thromboelastography. No major clinical problems or adverse events were noted during cooling or rewarming. Comparison with the noncooled group revealed no increase in mortality, bleeding, infection, or need for inotropes in infants who were cooled. CONCLUSIONS Mild hypothermia for 48 hours in preterm neonates with severe NEC seems both feasible and safe. Additional investigation of the efficacy of this therapeutic intervention in this population is warranted.

UI MeSH Term Description Entries
D007036 Hypothermia, Induced Abnormally low BODY TEMPERATURE that is intentionally induced in warm-blooded animals by artificial means. In humans, mild or moderate hypothermia has been used to reduce tissue damages, particularly after cardiac or spinal cord injuries and during subsequent surgeries. Induced Hypothermia,Mild Hypothermia, Induced,Moderate Hypothermia, Induced,Targeted Temperature Management,Therapeutic Hypothermia,Hypothermia, Therapeutic,Induced Mild Hypothermia,Induced Mild Hypothermias,Induced Moderate Hypothermia,Induced Moderate Hypothermias,Mild Hypothermias, Induced,Moderate Hypothermias, Induced,Targeted Temperature Managements
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007234 Infant, Premature A human infant born before 37 weeks of GESTATION. Neonatal Prematurity,Premature Infants,Preterm Infants,Infant, Preterm,Infants, Premature,Infants, Preterm,Premature Infant,Prematurity, Neonatal,Preterm Infant
D007235 Infant, Premature, Diseases Diseases that occur in PREMATURE INFANTS.
D009102 Multiple Organ Failure A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative. MODS,Multiple Organ Dysfunction Syndrome,Organ Dysfunction Syndrome, Multiple,Organ Failure, Multiple,Failure, Multiple Organ,Multiple Organ Failures
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005240 Feasibility Studies Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project. Feasibility Study,Studies, Feasibility,Study, Feasibility
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015850 Interleukin-6 A cytokine that stimulates the growth and differentiation of B-LYMPHOCYTES and is also a growth factor for HYBRIDOMAS and plasmacytomas. It is produced by many different cells including T-LYMPHOCYTES; MONOCYTES; and FIBROBLASTS. Hepatocyte-Stimulating Factor,Hybridoma Growth Factor,IL-6,MGI-2,Myeloid Differentiation-Inducing Protein,Plasmacytoma Growth Factor,B Cell Stimulatory Factor-2,B-Cell Differentiation Factor,B-Cell Differentiation Factor-2,B-Cell Stimulatory Factor 2,B-Cell Stimulatory Factor-2,BSF-2,Differentiation Factor, B-Cell,Differentiation Factor-2, B-Cell,IFN-beta 2,IL6,Interferon beta-2,B Cell Differentiation Factor,B Cell Differentiation Factor 2,B Cell Stimulatory Factor 2,Differentiation Factor 2, B Cell,Differentiation Factor, B Cell,Differentiation-Inducing Protein, Myeloid,Growth Factor, Hybridoma,Growth Factor, Plasmacytoma,Hepatocyte Stimulating Factor,Interferon beta 2,Interleukin 6,Myeloid Differentiation Inducing Protein,beta-2, Interferon

Related Publications

Nigel J Hall, and Simon Eaton, and Mark J Peters, and Melanie P Hiorns, and Nicholas Alexander, and Denis V Azzopardi, and Agostino Pierro
September 2022, European journal of pediatrics,
Nigel J Hall, and Simon Eaton, and Mark J Peters, and Melanie P Hiorns, and Nicholas Alexander, and Denis V Azzopardi, and Agostino Pierro
October 2021, European journal of pediatrics,
Nigel J Hall, and Simon Eaton, and Mark J Peters, and Melanie P Hiorns, and Nicholas Alexander, and Denis V Azzopardi, and Agostino Pierro
August 2019, Anaerobe,
Nigel J Hall, and Simon Eaton, and Mark J Peters, and Melanie P Hiorns, and Nicholas Alexander, and Denis V Azzopardi, and Agostino Pierro
July 2012, Early human development,
Nigel J Hall, and Simon Eaton, and Mark J Peters, and Melanie P Hiorns, and Nicholas Alexander, and Denis V Azzopardi, and Agostino Pierro
June 2010, Journal of perinatology : official journal of the California Perinatal Association,
Nigel J Hall, and Simon Eaton, and Mark J Peters, and Melanie P Hiorns, and Nicholas Alexander, and Denis V Azzopardi, and Agostino Pierro
January 2022, Archives of Iranian medicine,
Nigel J Hall, and Simon Eaton, and Mark J Peters, and Melanie P Hiorns, and Nicholas Alexander, and Denis V Azzopardi, and Agostino Pierro
January 2015, Journal of Ayub Medical College, Abbottabad : JAMC,
Nigel J Hall, and Simon Eaton, and Mark J Peters, and Melanie P Hiorns, and Nicholas Alexander, and Denis V Azzopardi, and Agostino Pierro
June 2008, American journal of obstetrics and gynecology,
Nigel J Hall, and Simon Eaton, and Mark J Peters, and Melanie P Hiorns, and Nicholas Alexander, and Denis V Azzopardi, and Agostino Pierro
January 2022, Frontiers in pediatrics,
Nigel J Hall, and Simon Eaton, and Mark J Peters, and Melanie P Hiorns, and Nicholas Alexander, and Denis V Azzopardi, and Agostino Pierro
March 2016, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians,
Copied contents to your clipboard!